The Peripheral Nerve Society
The Peripheral Nerve Society is an international organization of physicians and scientists working together to develop and provide the best treatments for people who have peripheral nerve diseases. This goal is realized by cooperation - supporting research, training scientists and healthcare professionals, setting standards of care, creating new treatments, and facilitating clinical trials.
The Peripheral Nerve Society was founded in 1994, having evolved from two groups of academic investigators interested in understanding the basic biology and function of the peripheral nervous system - the nature of nerve injury and repair. These groups met periodically in closed meetings to discuss advances in this understanding and how this knowledge might be applied to care for patients with genetic, traumatic, toxic, or metabolic nerve disease. The interests of our members encompass all aspects of the peripheral nervous system, both clinical and scientific, and range from electrophysiologic tools for diagnosis to molecular mechanisms of disease and nerve fiber regeneration. The Society is incorporated, and open to general membership by those interested in the peripheral nervous system and its diseases. DOWNLOAD application for PNS MEMBERSHIP. Complete the application form and fax to the Executive Secretary.
International Inflammatory Neuropathy Corsortium
The INC is a Standing Committee of the PNS with scheduled meetings and specific goals for education, treatment and research of the inflammatory neuropathies.
International Inflammatory Neuropathy Consortium
2014 PNS / INC Conference
July 13-16, 2014 Düsseldorf, Germany* Abstract Deadline - March 31st, 2014
* Registration Deadline - June 1st, 2013
Calling all researchers in Neuroimmunology…
Following the success of the third Interlaken Research Awards – a global initiative to support investigator-led research in the field of polyvalent immunoglobulin therapy in neuroimmunology – CSL Behring is pleased to invite for the fourth year of the program, a brief letter of intent from January 13 through March 3rd.
The goals of the Interlaken Leadership Awards program are:
- • To identify new clinical applications for immunoglobulin therapy.
- • To investigate the mechanisms of action of polyvalent immunoglobulins.
- • To enhance the quality of life of patients using polyvalent immunoglobulins.
Individuals actively engaged in clinical or basic research in a field of study consistent with the goals of this program are eligible for an award and are encouraged to submit research proposals.
No distinction will be made between applicants on the basis of gender, ethnic origin, geography, or religious or political beliefs.